How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

A Phase 1/1b Study of IAM1363, a selective and brain penetrant HER2 inhibitor

calendar_today October 19, 2025 person domain iambic

Clinical trial poster presentation detailing safety and efficacy findings from an early-stage cancer treatment study.

open_in_new Read original post